Insider Transactions in Q4 2025 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Bernadette Connaughton Director |
SELL
Open market or private sale
|
Direct |
829
-1.93%
|
$58,859
$71.6 P/Share
|
|
Dec 01
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
16,569
-0.57%
|
$1,143,261
$69.98 P/Share
|
|
Dec 01
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,569
+2.23%
|
$132,552
$8.11 P/Share
|
|
Nov 26
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Bona fide gift
|
Direct |
25,000
-3.41%
|
-
|
|
Nov 12
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-0.89%
|
$1,400,000
$70.99 P/Share
|
|
Nov 12
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Nov 11
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-0.89%
|
$1,360,000
$68.81 P/Share
|
|
Nov 11
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Nov 10
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.33%
|
$1,380,000
$69.01 P/Share
|
|
Nov 10
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Nov 10
2025
|
Bernadette Connaughton Director |
SELL
Open market or private sale
|
Direct |
2,000
-4.45%
|
$136,000
$68.48 P/Share
|
|
Nov 01
2025
|
Cortney Caudill SVP, CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,263
-25.08%
|
$277,095
$65.19 P/Share
|
|
Nov 01
2025
|
Cortney Caudill SVP, CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,326
+35.43%
|
-
|
|
Oct 03
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-0.67%
|
$1,400,000
$70.14 P/Share
|
|
Oct 03
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Oct 02
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-0.54%
|
$1,440,000
$72.35 P/Share
|
|
Oct 02
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Oct 01
2025
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.34%
|
$1,500,000
$75.4 P/Share
|
|
Oct 01
2025
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.58%
|
$160,000
$8.11 P/Share
|
|
Oct 01
2025
|
Bernadette Connaughton Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.15%
|
$150,000
$75.39 P/Share
|